Label-free impedimetric aptasensor with antifouling surface chemistry: A prostate specific antigen case study
Top Cited Papers
- 1 March 2015
- journal article
- Published by Elsevier BV in Sensors and Actuators B: Chemical
- Vol. 209, 306-312
- https://doi.org/10.1016/j.snb.2014.11.083
Abstract
No abstract availableKeywords
Funding Information
- European Commission (317420)
- Slovak Research and Development Agency (APVV 0282-11)
This publication has 41 references indexed in Scilit:
- Current Status of Biomarkers for Prostate CancerInternational Journal of Molecular Sciences, 2013
- Aberrant PSA glycosylation—a sweet predictor of prostate cancerNature Reviews Urology, 2013
- Biosensor developments: application to prostate-specific antigen detectionTrends in Biotechnology, 2007
- Biomarkers in Cancer Staging, Prognosis and Treatment SelectionNature Reviews Cancer, 2005
- Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer TreatmentJNCI Journal of the National Cancer Institute, 2005
- Novel electrical detection of label-free disease marker proteins using piezoresistive self-sensing micro-cantileversBiosensors and Bioelectronics, 2005
- Development and validation of a quantitative ELISA for the measurement of PSA concentrationClinica Chimica Acta; International Journal of Clinical Chemistry, 2002
- Development of ultra-high sensitivity bioluminescent enzyme immunoassay for prostate-specific antigen (PSA) using firefly luciferaseLuminescence, 2001
- Combination of Prostate-Specific Antigen, Clinical Stage, and Gleason Score to Predict Pathological Stage of Localized Prostate CancerJAMA, 1997
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerThe New England Journal of Medicine, 1991